H Mojtabavi, A Saghazadeh, N Rezaei - European Cytokine Network, 2020 - Springer
Background Evidence links COVID-19 severity to hyper-inflammation. Treatment with
tocilizumab, a monoclonal antibody directed against the interleukin-6 (IL-6) receptor, was …